Consumer Ingredients: DSM-Firmenich Eau-vertaking Givaudan
Institutional-grade analysis used by equity desks before repricing events. 33 pages.
Report fact snapshot
- Publisher
- Bernstein
- Date
- 2026-08-18
- Type
- Industry Report
- Region
- Middle East
- Companies
- Target, European Household, Firmenich Eau, Firmenich
Market is pricing this as noise.
Data shows a structural shift is underway.
Sector models are broken — re-rating is imminent.
Based on Bernstein research, August 2026 data and regional breakdowns
Key Research Signals
Market is pricing this as noise.
Data shows a structural shift is underway.
Why it matters: Identifies the exact point where consensus models diverge from actual data.
A re-rating catalyst is approaching.
Consensus has not yet reflected this shift.
Why it matters: Frames the catalyst window before violent repricing begins.
Winners are concentrated in this space.
Specific companies are structurally outperforming.
Why it matters: Tracks the capital rotation toward structural winners before it becomes consensus.
What You Gain From This Report
Decision Insight
Mispricing is not yet reflected in consensus models.
Missed Risk
Without the full report, you miss the company-level breakdown that separates winners from losers.
Timing Advantage
The catalyst window is open now — consensus repricing will close it within quarters.
What you miss without the full report:
- Company-level positioning and stock picks
- Valuation assumptions and model inputs
- Price target logic and catalyst timeline
Why Institutional Investors Care
Mispricing windows like this typically precede sector re-rating events.
Early positioning in structural winners often leads to outsized returns when consensus catches up.
The catalyst window narrows as monthly data becomes consensus, making near-term positioning critical.
Report Summary
We believe DSM-Firmenich is at the start of a multi-year fragrance share recovery story that is still underappreciated by the market. Since the 2023 Firmenich merger, DSM-Firmenich's Perfume & Beauty division has underperformed peers, while Givaudan has been the main beneficiary, gaining significant share in both Fine and Consumer
Institutional Content Below
Full PDF (33 pages), valuation models, broker logic, and detailed charts.
Key Takeaways
- 3% consensus). Conversely, we expect Givaudan's fragrance market shares to stabilise
- , then underperformed since 2023. This has translated to c.2.5pp lost share in Fine Fragrances and c.2pp in Consumer
- 1% 56.9% 57.5% 57.9% 57.5% 56.6% 56.3% 55.7% 55.1%
Topics Covered
Companies Mentioned
Who this summary is for
This summary is for users researching the Bernstein Consumer Ingredients report. It helps users review Consumer Ingredients: DSM-Firmenich Eau-vertaking Givaudan coverage, key takeaways, and related broker or sector research paths across Consumer, revenue, merger; Target, European Household.
Related Search Paths
Use these links to continue through broker, sector and report-type research summaries.
Request Full PDF Access
Get access to the full broker report, including company-level details, valuation assumptions, charts, and price target logic.
Access is provided through VIP service or request confirmation.